Juan-Pablo Mas

Juan-Pablo Mas is a Partner at Action Potential Venture Capital since August 2014, focusing on investments in Bioelectronic Medicines, Precision Diagnostics (AI), and Computational Biology. Additionally, Juan-Pablo holds board memberships at Onc.AI, Exo Imaging, Inc., Saluda Medical, Presidio Medical, SetPoint Medical, and Gradient Denervation Technologies, while serving as a board observer for Neuspera Medical Inc. and as a board member for Cala Health. Involved with the Wu Tsai Neurosciences Institute, Juan-Pablo contributes to the Translational Oversight Committee. Juan-Pablo holds an MBA from Stanford University Graduate School of Business, a Master’s degree in Electrical Engineering from Stanford University, and a Bachelor’s degree in Electrical Engineering with a Minor in Mathematics from the University of Massachusetts Amherst.